Favorable Conception and Pregnancy Involving a Male Patient Affected by Chronic Myeloid Leukemia While Taking Dasatinib
Overview
Authors
Affiliations
Elsabagh A, Benkhadra M, Elmakaty I, Elsayed A, Elsayed B, Elmarasi M Cancers (Basel). 2024; 16(4).
PMID: 38398181 PMC: 10886940. DOI: 10.3390/cancers16040791.
Severe male factor in fertilization: definition, prevalence, and treatment. An update.
Mazzilli R, Vaiarelli A, Dovere L, Cimadomo D, Ubaldi N, Ferrero S Asian J Androl. 2021; 24(2):125-134.
PMID: 34259196 PMC: 8887096. DOI: 10.4103/aja.aja_53_21.
Szakacs Z, Hegyi P, Farkas N, Hegyi P, Balasko M, Eros A PLoS One. 2020; 15(12):e0243045.
PMID: 33270732 PMC: 7714354. DOI: 10.1371/journal.pone.0243045.
The impact of dasatinib on pregnancy outcomes.
Cortes J, Abruzzese E, Chelysheva E, Guha M, Wallis N, Apperley J Am J Hematol. 2015; 90(12):1111-5.
PMID: 26348106 PMC: 5115878. DOI: 10.1002/ajh.24186.
Grazia Recchia A, Caruso N, Bossio S, Pellicano M, de Stefano L, Franzese S PLoS One. 2015; 10(6):e0130360.
PMID: 26111048 PMC: 4482505. DOI: 10.1371/journal.pone.0130360.